Hormone replacement therapy (HRT) nearly triples the risk of breast cancer, according to a lengthy study by the Institute of Cancer Research and Breast Cancer Now; about 14 in 1,000 women in their 50s are expected to develop breast cancer, but that rises to 34 in 1,000 for women taking the combined pill, says the study. The findings were published online Monday in the British medical journal BMJ. (Nice) who encouraged more doctors to prescribe HRT.
Hormone replacement therapy (HRT) nearly triples the risk of breast cancer, according to a lengthy study by the Institute of Cancer Research and Breast Cancer Now; about 14 in 1,000 women in their 50s are expected to develop breast cancer, but that rises to 34 in 1,000 for women taking the combined pill, says the study. This follows advice last year from the National Institute of Health and Care Excellence (Nice) who encouraged more doctors to prescribe HRT.